EPIDAREX CAPITAL

epidarex-capital-logo

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capitalโ€™s investors represent a cross-section of leading universities, international corporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

#People #Financial #More

EPIDAREX CAPITAL

Social Links:

Industry:
Angel Investment Life Science Venture Capital

Founded:
2010-01-01

Status:
Active

Contact:
301 298 5455

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Font Awesome Wordpress Plugins Microsoft Exchange Online Office 365 Mail


Current Employees Featured

peter-finan_image

Peter Finan
Peter Finan Partner @ Epidarex Capital
Partner
2014-08-01

not_available_image

Elizabeth Roper
Elizabeth Roper Partner @ Epidarex Capital
Partner
2013-04-01

not_available_image

Kyparissia Sirinakis
Kyparissia Sirinakis Founder & Managing Partner @ Epidarex Capital
Founder & Managing Partner
2010-10-01

not_available_image

Sinclair Dunlop
Sinclair Dunlop Managing Partner @ Epidarex Capital
Managing Partner
2010-01-01

Founder


not_available_image

Kyparissia Sirinakis

Investments List

Date Company Article Money raised
2022-05-31 Transine Therapeutics Epidarex Capital investment in Seed Round - Transine Therapeutics 4.6 M GBP
2022-04-07 Kynos Therapeutics Epidarex Capital investment in Seed Round - Kynos Therapeutics 6.5 M GBP
2022-03-02 Epsilogen Epidarex Capital investment in Series B - Epsilogen 30.75 M GBP
2021-11-02 Dunad Therapeutics Epidarex Capital investment in Series A - Dunad Therapeutics 24 M USD
2021-10-21 Leucid Bio Epidarex Capital investment in Series A - Leucid Bio 11.5 M GBP
2021-07-29 Topas Therapeutics Epidarex Capital investment in Series B - Topas Therapeutics 18 M EUR
2021-07-29 Macomics Epidarex Capital investment in Seed Round - Macomics 4.24 M GBP
2021-06-23 RapidPulse Epidarex Capital investment in Series A - RapidPulse 15 M USD
2021-05-17 Lunac Therapeutics Epidarex Capital investment in Venture Round - Lunac Therapeutics 4.75 M GBP
2021-03-23 Dunad Therapeutics Epidarex Capital investment in Seed Round - Dunad Therapeutics N/A

More informations about "Epidarex Capital" on Search Engine